BCTX: BriaCell Therapeutics Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 35.64
Enterprise Value ($M) 29.15
Book Value ($M) -8.32
Book Value / Share -0.52
Price / Book -4.28
NCAV ($M) -8.81
NCAV / Share -0.55
Price / NCAV -4.05

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.37
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.99
Current Ratio 2.99

Balance Sheet (mrq) ($M)
Current Assets 11.74
Assets 12.23
Liabilities 20.55
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -23.27
Net Income -20.30

Cash Flow Statement (mra) ($M)
Cash From Operations -23.74
Cash from Investing 0.00
Cash from Financing 3.95

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 2,325 18,029 12.90
2024-04-25 2,717 2,631 103.27
2024-04-24 2,056 8,769 23.45
2024-04-23 6,799 6,310 107.75
2024-04-22 5,045 2,614 193.00

(click for more detail)

Similar Companies
AYTU – Aytu BioPharma, Inc. BCDA – BioCardia, Inc.
BCLI – Brainstorm Cell Therapeutics Inc. BFRG – Bullfrog AI Holdings, Inc.
BFRI – Biofrontera Inc.


Financial data and stock pages provided by
Fintel.io